Materials and Reagents
- Transfection HBV 1.2mer replicons
- Huh7 cells (Liver Research Center, Rhode Island Hospital, Brown Medical School, Providence, USA)
- Dulbecco modified Eagle medium (DMEM) (Life Technologies, Gibco®, catalog number: 11995 )
- Fetal bovine serum (FBS) (Life Technologies, Gibco®, catalog number: 26140-079 )
- Penicillin-streptomycin (Life Technologies, Gibco®, catalog number: 15140 )
- Lipofectamine 2000 (Life Technologies, InvitrogenTM, catalog number: 11668-019 )
- Opti-MEM® I Reduced Serum Medium (Opti-MEM) (Life Technologies, Gibco®, catalog number: 31985-088 )
- HBV 1.2mer replicon [WT or Drug-resistant HBV, WT HBV1.2 replicon was kindly provided from Prof. W. S. Ryu (Yonsei University, Korea)]
- Lamivudine (1~100 μM, provided by GlaxoSmithKline)
- Adefovir (1~100 μM, provided by Gilead Sciences)
- Clevudine (1~100 μM, provided by Bukwang Pharmaceutical Co.)
- Entecavir (0.05~1 μM, Moravek)
- Tenofovir (1~100 μM, provided by Gilead Sciences)
- Extraction of viral DNA from HBV core particles
- DNaseI (Takara Bio Company, catalog number: 2215B )
- MungBean Nuclease (Takara Bio Company, catalog number: 2420B )
- Proteinase K (Roche Diagnostics, catalog number: 03115801001 )
- Phenol-chloroform-isoamyl alcohol 25:24:1 (Sigma-Aldrich, catalog number: 77617 )
- Sodium acetate trihydrate (NaOAc) (Sigma-Aldrich, catalog number: 236500 )
- HEPES lysis buffer (see Recipes)
- Nuclease buffer (I) (see Recipes)
- 26% PEG solution (see Recipes)
- Nuclease buffer (II) (see Recipes)
- 0.5% SDS solution (see Recipes)
- Southern blot assay and the construction of the HBV probe
- Certified Molecular Biology Agarose (Bio-Rad Laboratories, catalog number: 161-3102 )
- Amersham Hybond-N+ membrane (GE Healthcare, catalog number: RPN203B )
- SSC Buffer (Sigma-Aldrich, catalog number: 85639 )
- Salmon sperm DNA (Life Technologies, InvitrogenTM, catalog number: AM9680 )
- Poly ethylene glycol (PEG) (Sigma-Aldrich, catalog number: P5413 )
- 50x Denhardt’s solution (Sigma-Aldrich, catalog number: D2532 )
- 0.1 M sodium phosphate buffer (pH 7.0)
- Formamide (Sigma-Aldrich, catalog number: F7503 )
- HBV 1.2mer replicon
- Klenow fragment and 10x Klenow buffer (Takara Bio Company, catalog number: 2140B )
- dNTP (NEB, catalog number: N0446S )
- [α-32P] dCTP (3,000 Ci/mmole, Perkin Elmer, catalog number: BLU513H500UC )
- Quick Spin Columns for radiolabeled DNA purification (Sephadex G-50, Roche Diagnostics, catalog number: 11 273 973 001 )
- Aat II (New England BioLabs, catalog number: R0117S )
- Hind III (New England BioLabs, catalog number: R0104S )
- Random primer (Bioneer, catalog number: N-7052 )
- Na2HPO4 (Amresco, catalog number: 0404 )
- NaH2PO4 (Amresco, catalog number: 0571 )
- 0.1 M sodium phosphate buffer (see Recipes)
- Transfer solution (I) (see Recipes)
- Transfer solution (II) (see Recipes)
- Transfer solution (III) (see Recipes)
- Hybridization solution (see Recipes)
- Washing solution (I) (see Recipes)
- Washing solution (II) (see Recipes)
Equipment
- 37 °C, 5% CO2 forced-air incubator (Thermo Fisher Scientific, Forma®, model: 3131 )
- 100 mm cell culture dish (Nunc®, catalog number: 172958 )
- 6 well plate (Nunc®, catalog number: 140675 )
- Centrifuge (Eppendorf, catalog number: 5415R )
- Pipet Aid XP (Drummond Scientific Company)
- Electrophoresis system (Nihon Eido, catalog number: NB-1011 )
- Dry oven
- Hybridization bottle
- Hybridization chamber
- Heat block
Procedure
- Transfection of HBV 1.2mer replicons
- One day before transfection, plate 3 x 105 Huh7 cells per well in 2 ml of growth medium (DMEM with 10% FBS, 1% Penicillin-streptomycin) on 6 well plate.
- Two hours before transfection, change 2 ml of growth media per well at 80% cells confluence.
- Dilute the 2 μg of HBV 1.2mer replicons in 125 μl of Opti-MEM and gently flick.
- Dilute 4 μl of Lipofectamine 2000 in 125 μl of Opti-MEM and gently flick. Then, incubate for 5 min at room temperature.
- After 5 min incubation, combine the diluted HBV 1.2mer replicons with the diluted Lipofectamine 2000 and gently mix by pipetting. Then, incubate for 20 min at room temperature.
- After 4~6 h transfection, change 2 ml of growth medium per well mixed with appropriate concentration anti-HBV drugs (see Figure 2).
- Replace the growth medium with anti-HBV drugs every day for 4 days and, then harvest the cells in 1.5 ml tube by centrifugation at 3,000 rpm for 1 min at 4 °C.
- Extraction of core particle relative HBV DNA
- Add 100 μl of cold HEPES lysis buffer in cell pellet and incubate on ice for 20 min.
- Centrifuge the lysates at 13,000 rpm for 10 min at 4 °C and transfer supernatant (cell lysate, cytoplasm fraction) into new 1.5 ml tube.
- Mix 5.67 μl of nuclease buffer (I) by pipetting and incubate for 30 min in 37 °C water bath.
- Briefly spin down, add 40 μl of 26% PEG solution and incubate for 2 h on ice (vortexing every 30 min) and centrifuge at 13,000 rpm for 30 min at 4 °C.
- Discard the supernatant and centrifuge at 13,000 rpm for 5 min at 4 °C.
- Completely remove the supernatant (using pipet and KIMTECH Science Wipers).
- Add 100 μl of nuclease buffer (II) and physically resuspend the core particles.
- Incubate for 20 min in 37 °C water bath and briefly spin down.
- Add 282.5 μl of 0.5% SDS solution and 12.5 μl of proteinase K (20 mg/ml) and incubate for 2~4 h in 37 °C water bath (inverting every 30 min).
- After spin down, add 400 μl of phenol-chloroform-isoamyl alcohol and vigorously vortex for 10 sec. Then, centrifuge at 13,000 rpm for 5 min at room temperature.
- Transfer aqueous upper layer into new 1.5 ml tube.
- Add 40 μl of 3 M NaOAc and 800 μl of 100% ethanol. After inverting several times, precipitate the mixture overnight at -20 °C.
- Centrifuge at 13,000 rpm for 30 min at 4 °C and throw away the supernatant.
- Add 800 μl of 70% ethanol and gently inverting.
- Centrifuge at 13,000 rpm for 10 min at 4 °C and throw away the supernatant.
- Add 800 μl of 100% ethanol and gently inverting.
- Centrifuge at 13,000 rpm for 10 min at 4 °C and throw away the supernatant.
- Dry the HBV DNA pellet for 5~10 min (air-drying) and dissolve in 15 μl of TE buffer. Store HBV DNA at 4 °C until use.
- Southern blot assay (gel transfer)
- Separate HBV DNA (procedure B, step 18) on 0.8% agarose gel for 2 h at 89 V.
- After electrophoresis, transfer the gel to tray and add transfer solution (I) to soak the gel.
- Incubate for 10 min on shaker and rinse the gel with distilled water.
- Add transfer solution (II) and incubate for 45 min on shaker.
- Rinse with distilled water and add transfer solution (III).
- Incubate over 30 min on shaker and rinse the gel with distilled water.
- Transfer the gel to Hybond-N+ membrane for overnight using capillary method (Figure 1) and bake the membrane to fix the HBV DNA for 2 h in 80 °C dry oven.
- Place membrane in hybridization bottle contained with 25 ml hybridization solution and incubates the membrane for 4 h in 42 °C hybridization chamber (pre-hybridization step).
- The construction of the HBV probe
- To construct a template for the HBV specific probe, digest HBV 1.2mer replicon with Aat II and Hind III for 2 h at 37 °C and gel purification (Ahn et al., 2015).
- To synthesis HBV specific probe, mix the 48 ng of template (step 8) and 80 ng of random primer in 50 μl of distilled water.
Note: Step 10 should be carried out during pre-hybridization step.
- Heat the probe mixtures for 5 min at 100 °C and snap cooling on ice for 5 min.
- After spin down, add 5ul of 10x Klenow buffer, 2.5 μl of the dNTPs mixtures (2.5 mM, except dCTP), 5 μl of 32P-labled dCTP (50 μCi=5 μl/labeling), and 1 μl of Klenow fragment in probe mixtures.
- Incubate the probe mixture for 30 min at 37 °C.
- Remove the non-labeled probe using Quick Spin Columns for radiolabeled DNA purification.
- Southern blot assay (membrane hybridization)
- Replace pre-warmed 25 ml of hybridization solution with 32P-labled HBV probe and incubate overnight in 42 °C hybridization chamber.
- After hybridization step, wash the membrane with washing solution (I) for 15~20 min in 63 °C hybridization chamber.
Note: If need more washing step, repeat wash with washing solution (II). Steps 9~16 should be performed in the Radio isotope room.
- Expose membrane to film and incubate overnight at -80 °C deep freezer. Then, develop the film.
Representative data

Figure 1. Scheme of capillary transfer method for Southern blotting

Figure 2. In vitro susceptibility assay of drug-resistant HBV (Kim et al., 2014). The replication of drug-resistant HBV was analyzed by Southern blot. TDF and ETV were treated with concentration as followed table (below).
Recipes
- HEPES lysis buffer
10 mM Hepes (pH 7.5)
100 mM NaCl
1 mM EDTA
1% NP-40
- Nuclease buffer (I)
10 mM CaCl2
12 mM MgCl2
DNaseI 0.5 unit
Mung Bean nuclease 7.5 unit
- 26% PEG solution
1.2 M NaCl
60 mM EDTA
30% sucrose
26% PEG 8000
- Nuclease buffer (II)
10 mM Tris (pH 7.5)
8 mM CaCl2
6 mM MgCl2
DNaseI 2 unit
Mung Bean nuclease 3 unit
- 0.5% SDS solution
25 mM Tris (pH 7.5)
10 mM EDTA
100 mM NaCl
0.5% SDS
- 0.1 M sodium phosphate buffer (pH 7.0)
57.7 ml of 1 M Na2HPO4
42.3 ml of 1 M NaH2PO4
- Transfer solution (I)
0.25 N HCl
0.6 M NaCl
- Transfer solution (II)
0.5 M NaOH
1 M NaCl
- Transfer solution (III)
1 M Tris (pH 7.5~8.0)
1 M NaCl
- Hybridization solution
Formamide 25 ml
20x SSC 12.5 ml
0.1 M sodium phosphate buufer (pH 7.0) 2.5 ml
0.5 M EDTA 0.2 ml
50x Denhardt’s solution 3 ml
10% SDS 1 ml
Salmon sperm DNA (10 mg/ml) 1 ml
Distilled water 4.8 ml
- Washing solution (I)
2x SSC
0.1% SDS
- Washing solution (II)
0.5x SSC
0.1% SDS
Acknowledgments
This study was supported by Konkuk University.
References
- Ahn, S. H., Park, Y. K., Park, E. S., Kim, J. H., Kim, D. H., Lim, K. H., Jang, M. S., Choe, W. H., Ko, S. Y., Sung, I. K., Kwon, S. Y. and Kim, K. H. (2014). The impact of the hepatitis B virus polymerase rtA181T mutation on replication and drug resistance is potentially affected by overlapping changes in surface gene. J Virol 88(12): 6805-6818.
- Ahn, S. H., Park, Y. K. and Kim, K. (2015). Introduction and sequencing of patient-isolated HBV RT sequences into the HBV 1.2-mer replicon. Bio-protocol 5(8): e1449.
- Kim, J. H., Park, Y. K., Park, E. S. and Kim, K. H. (2014). Molecular diagnosis and treatment of drug-resistant hepatitis B virus. World J Gastroenterol 20(19): 5708-5720.
- Kwon, S. Y., Park, Y. K., Ahn, S. H., Cho, E. S., Choe, W. H., Lee, C. H., Kim, B. K., Ko, S. Y., Choi, H. S., Park, E. S., Shin, G. C. and Kim, K. H. (2010). Identification and characterization of clevudine-resistant mutants of hepatitis B virus isolated from chronic hepatitis B patients. J Virol 84(9): 4494-4503.
Article Information
Copyright
© 2015 The Authors; exclusive licensee Bio-protocol LLC.
Category
Microbiology > Antimicrobial assay > Antiviral assay
Microbiology > Microbe-host interactions > Virus
Microbiology > Microbe-host interactions > In vitro model